IBRUNAT 140MG CAP
Prescription Required
₹ 8,906.25
Inclusive of all taxes.
Couldn't load pickup availability
IBRUNAT 140MG CAP
Regular price
₹ 8,906.25
Regular price
Sale price
₹ 8,906.25
(-0%)
Unit price
per
IBRUNAT 140MG CAP
₹ 8,906.25
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Ibrunat 140mg Capsule contains ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor that slows the growth and survival of certain blood cancer cells.
Uses
Ibrunat 140mg Capsule is used for the treatment of B-cell blood cancers.
- Chronic lymphocytic leukaemia (CLL)
- Mantle cell lymphoma
- Waldenström macroglobulinaemia
- Other approved B-cell malignancies
Storage
- Store below 30°C in a cool, dry place.
- Keep away from moisture and sunlight.
Safety Information
- Monitor blood counts and signs of bleeding or infection.
- Avoid grapefruit products.
- Inform your doctor about anticoagulants or heart rhythm disorders.
Possible Side Effects
Possible side effects may include:
- Diarrhoea
- Fatigue
- Bruising
- Bleeding
- Low blood cell counts
- Infections
- Muscle pain
- Atrial fibrillation
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Ibrunat is a prescription targeted anticancer medicine.
It should only be used under the supervision of a qualified oncologist.